Aardvark Therapeutics, Inc. (AARD)
Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
5. 86
-0.47
-7.425%
$
165.8M Market Cap
- P/E Ratio
- Div Yield
218,400 Volume
- Eps
$ 6.33
Previous Close 
Want to track AARD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
AARD Earnings Reports FAQ
What is the earnings per share (EPS) for AARD?
EPS data for AARD is currently not available, as Aardvark Therapeutics, Inc has not reported recent earnings.
What is the company's earnings growth rate?
Aardvark Therapeutics, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Aardvark Therapeutics, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Aardvark Therapeutics, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for AARD at this time, as Aardvark Therapeutics, Inc has no recent EPS data to calculate it.
